Melden Sie sich bei getAbstract an, um die Zusammenfassung zu erhalten.

Innovation in Life Sciences

Melden Sie sich bei getAbstract an, um die Zusammenfassung zu erhalten.

Innovation in Life Sciences

An Emerging Markets Perspective

EIU,

5 Minuten Lesezeit
5 Take-aways
Audio & Text

Was ist drin?

Being at the forefront of scientific development requires innovation – but what does being “innovative” entail?

automatisch generiertes Audio
automatisch generiertes Audio

Editorial Rating

9

Qualities

  • Analytical
  • Scientific
  • Overview

Recommendation

What does it take for a newcomer in the life sciences to catch up to Western European and North American players? According to this well-researched and informative analysis by The Economist Intelligence Unit, the number one requirement is innovation. Established Western players have the know-how, the resources and the experience. To catch up in the pharmaceutical race, emerging players have to find new ways to be innovative. getAbstract recommends this report to innovators in any field interested in advancing their business ventures.

Summary

Developing strong, innovative companies in the life sciences sectors is a challenge due to the scientific expertise and regulations needed. Historically, North American and European companies have had an advantage. However, a few new players such as Brazil, India, China, South Korea, Costa Rica and Singapore are proving that they can also becoming leaders.

Innovation is the secret to success for emerging economies. But, how does a country become innovative in the life sciences sector? Answering that question requires a definition of “innovation. Innovation...

About the Author

The Economist Intelligence Unit is the research and analysis department of The Economist Group.


Comment on this summary

More on this topic

By the same author

8
Report
8
Article
7
Report
7
Report
8
Report
7
Report
8
Report
8
Report
7
Report
8
Report
7
Report
8
Report
7
Report
7
Report
7
Report
8
Report
8
Report